"We are in uncharted territory as a result of the COVID-19 pandemic. Roche Ireland are using our platforms and website to direct you to reliable resources to help during this time of crisis. We can fight this disease through working together and by changing our behaviours. We hope that the information below is of help. Now is the time for solidarity."

 

Roche COVID-19 Q&A

Roche takes the health and safety of our patients, customers, employees and community very seriously, and we are actively responding to the global COVID-19 pandemic. We are closely monitoring and evaluating the situation as it evolves. Patient safety and ensuring continuity of care are critical priorities for us at Roche. We are continually monitoring and adapting our business practices to minimize any potential delays/disruptions that may have patient-level impact, while prioritising community health.

You will find responses to frequently asked questions below. If you don’t find the answer to your question here, please contact one of our support resources listed on this page.

 

Will product supply and delivery be affected?

Roche continues to assess the potential implications to its manufacturing and supply operations in real time. In line with Health Service Executive (HSE) regulations, Roche Products (Ireland) Ltd currently has at least 12 weeks or more of forecasted requirements of all of its medicines available in the Republic of Ireland. These medicines are on allocation, which means that Roche has control over what stock goes out and monitors this on a daily basis, in order to ensure there is no stock piling. Based on current demand forecasts, available stock, and the latest information from our suppliers, Roche is currently not facing any shortages of medicinal products with the potential exception of RoActemra (tocilizumab).  Demand for RoActemra  (tocilizumab) has increased significantly due to off-label treatment of patients impacted by COVID-19.

Ongoing mitigation actions and business continuity strategies are being taken to reduce the risk of a stock-out of RoActemra in the Republic of Ireland and Roche remains in close contact with the HSE, with healthcare providers and with suppliers.

Should Roche become aware of any change to the supply or availability of any of its medicines at any point, it will inform the HSE and HPRA as well as relevant healthcare providers and patient groups.

 

Customers: There is currently no issue with the availability of any Roche medicines in the Republic of Ireland. If you experience delays while ordering a Roche medicine, this may be due to a local issue. Please bear with your supplier during this time.  Please liaise with your supplier as the first line of enquiry. If the issue persists, please contact Roche Supply Chain on +353 (0)1 469 0700.

 

Patients: There is currently no issue with the availability of any Roche medicines in the Republic of Ireland. If you have a concern about your health or your treatment, please contact your healthcare team. Information about the coronavirus is available at hse.ie/coronavirus/

[Updated 23 March 2020]

 

What if I have questions about my Roche medicines?

We have a dedicated online form for specific queries related to Roche products online here: https://www.roche.ie/en/medical-information.html

You can also call us on +353 (0)1-4690700 (ext 4) or email [email protected]

 

Where can I get trusted source of information on Covid-19?

Ireland’s Health Service Executive (HSE) provides the most reliable and up to date information for COVID-19 in Ireland and the steps we, as a country, are taking to tackle it. Read more here:

https://www2.hse.ie/conditions/coronavirus/coronavirus.html

 

I think I'm in the at-risk category. What should I do?

The HSE defines those at risk of serious illness upon catching the coronavirus as:

  • 60 years of age and over
  • having a long-term medical condition - for example, heart disease, lung disease, diabetes, cancer, cerebrovascular disease, renal disease, liver disease or high blood pressure
  • having a weak immune system (immunosuppressed)
  • having a medical condition that can affect your breathing
  • are in specialist disability care and are over 50 years of age or have an underlying health problem
  • residents of nursing homes and other long-stay settings 
  • are in specialist disability care and are over 50 years of age or have an underlying health problem.

If this describes you, follow the below link for more information from the HSE. Equally, please check the HSE website for the latest definition as the situation is continuing to evolve: https://www2.hse.ie/conditions/coronavirus/at-risk-groups.html

 

What is Roche doing to prepare for and protect against the transmission of COVID-19 on its campus?

Roche takes the health and safety of our employees, their families and our local communities very seriously, and we are actively responding to the COVID-19 public health issue.

We have a COVID-19 Task Force dedicated to ensuring the critical work required to bring our medicines to those who need them continues. The measures we have put in place include:

  • Requiring those who are able to work from home to do so and restricting access to our campus only to personnel needed to carry out essential business continuity activities on site.
  • Encouraging virtual rather than in-person interactions across the country to continue to meet the needs of our customers and their patients.
  • Restricting all global and domestic company air travel only to trips that support business continuity.
  • Cancelling/postponing all in-person Roche meetings and events.
  • Suspending visitor access to our campus and conducting virtual meetings.
  • Fully complying with all HSE and applicable government regulations and protocols.

 

What is Roche doing to support communities during the COVID-19 pandemic?

The patient communities we work with are at the heart of everything we do. We have reached out to patient organisations that we regularly work with to ask how we can support them, their service users and members at this difficult time. We are actively working with groups such as MS Ireland and the Marie Keating Foundation to ensure that vulnerable members of our community have the information and support that they need. Roche employees are volunteering their time, energy and expertise to patient organisations and the health service. The company is also giving grants. We are committed to the ethos that #WeWillGetThroughThisTogether.

 

Scientist looking through microscope

 

Where can I find customer  information about  Roche Diagnostics product availability and ongoing service support?

Please click here to read a letter to Roche Diagnostics customers.. Please note that you will need to exit the Roche Ireland website and visit the Roche UK website to view this letter. 

 

Some useful resources

Below is a link to the dedicated HSE dedicated COVID-19 resource:

https://www2.hse.ie/coronavirus/

 

We will be using our Twitter channel to publish updates. You can follow us here:

https://twitter.com/rocheirl

 

We also recommend following the below Twitter accounts throughout this pandemic, to ensure you’re up to date with the latest developments. Below you’ll find links to trusted patient groups’ Twitter accounts as well as trusted news sources.

 

Patient Groups

https://twitter.com/ILFA_Ireland

https://twitter.com/MarieKeating

https://twitter.com/Arthritisie 

https://twitter.com/IrishCancerSoc

https://twitter.com/MSIRELAND

 

News Sources

https://twitter.com/hseNCCP

https://twitter.com/profmaryhorgan 

https://twitter.com/DubFireBrigade

https://twitter.com/GardaTraffic 

https://twitter.com/simoncoveney

https://twitter.com/CMOIreland 

https://twitter.com/HSELive

https://twitter.com/SimonHarrisTD 

https://twitter.com/Roche

https://twitter.com/IrishTimes 

https://twitter.com/rtenews